Guidance Brief
Selected findings from ECDC and EMCDDA scientific guidance, 2018
Practical Guidance for collaborative interventions
The World Drug Report 2022 is aimed not only at fostering greater international cooperation to counter the impact of the world drug problem on health, governance and security, but also, with its special insights, at assisting Member States in anticipating and address-ing threats from drug markets an...d mitigating their consequences.
more
Constituting the fourth part of the World Drug Report 2022, this booklet focuses on the market dynamics of various stimulants – cocaine, amphetamines and “ecstasy” – and of NPS.
The first chapter contains an analysis of the global market for cocaine, starting with a review of cocaine supply..., including trends in the cultivation of coca bush and in the manufacture of and trafficking in cocaine at the global level and in the various regions. An analysis of different eradication strategies is included, as well as of the role of women in the cocaine supply chain. The chapter also presents the latest estimates of and trends in cocaine use, including a brief introduction to the various cocaine consumer products. Finally, it reviews the trends in the use of cocaine and the impact of the coronavirus disease (COVID-19) pandemic in different regions
more
Report by the Director-General. 75th World health assembly 25 April 2022
How WHO works to prevent drug use, reduce harm and improve safe access to medicines
USAID Office of HIV/AIDS
March 8-9, 2016
Technical Brief
HIV patient monitoring and case surveillance
WHO/HIV/2017.14
PQDx 0197-045-00 WHO
PQDx PR
March /2016, version 2.0
Recommended actions at international and national levels